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AbsTRACT
Objective To establish European League Against 
Rheumatism (EULAR) points to consider for non- physician 
health professionals to prevent and manage fragility 
fractures in adults 50 years or older.
Methods Points to consider were developed in 
accordance with EULAR standard operating procedures 
for EULAR- endorsed recommendations, led by an 
international multidisciplinary task force, including patient 
research partners and different health professionals from 
10 European countries. Level of evidence and strength 
of recommendation were determined for each point to 
consider, and the mean level of agreement among the task 
force members was calculated.
Results Two overarching principles and seven points to 
consider were formulated based on scientific evidence and 
the expert opinion of the task force. The two overarching 
principles focus on shared decisions between patients and 
non- physician health professionals and involvement of 
different non- physician health professionals in prevention 
and management of fragility fractures. Four points to 
consider relate to prevention: identification of patients 
at risk of fracture, fall risk evaluation, multicomponent 
interventions to prevent primary fracture and 
discouragement of smoking and overuse of alcohol. The 
remaining three focus on management of fragility fractures: 
exercise and nutritional interventions, the organisation 
and coordination of multidisciplinary services for post- 
fracture models of care and adherence to anti- osteoporosis 
medicines. The mean level of agreement among the task 
force for the overarching principles and the points to 
consider ranged between 8.4 and 9.6.
Conclusion These first EULAR points to consider for 
non- physician health professionals to prevent and manage 
fragility fractures in adults 50 years or older serve to guide 
healthcare practice and education.
InTROduCTIOn
Countries across the world are facing a fragility 
fracture crisis.1 Estimates suggest that by 2040 over 
300 million adults age 50 years or more worldwide 
will be at high- risk of fragility fracture.2 In 2017, 
across France, Germany, Italy, Spain, Sweden and 
the UK alone, there were 2.68 million new fragility 
fractures, costing an estimated €37.5 billion.3 These 
numbers are projected to rise, such that in 2030 over 
3.3 million new fractures are anticipated across the 
same six countries, with accompanying total fracture- 
related costs approximating €47.4 billion.3
Many fragility fractures require immediate 
acute fracture care and typically lead to physical 
disability, persistent pain, impaired quality of life 
and increased mortality.4 Among those who sustain 
a fragility fracture, the risk of imminent subsequent 
Key messages
What is already known about this subject?
 ► Interventions delivered by non- physician 
health professionals to prevent and manage 
fragility fractures contribute to optimal patient 
outcomes. They have not been sufficiently 
covered to date in existing European League 
Against Rheumatism/European Federation of 
National Associations of Orthopaedics and 
Traumatology recommendations.
What does this study add?
 ► This paper will guide clinical practice in Europe 
regarding interventions delivered by non- 
physician health professionals to prevent and 
manage fragility fractures in adults 50 years 
or older. Several areas described in this paper 
highlight the necessity for further research. 
Future studies could build on our findings. 
International and national initiatives may 
find our paper useful as a common European 
reference.
 ► Prevention of fragility fractures is essential 
for good health in older age; osteoporosis 
and fractures are key issues that need to be 
considered. Especially vulnerable patient 
groups, for example, frail older people, 
and those with cognitive impairments will 
benefit from European standards regarding 
interventions delivered by non- physician 
health professionals to prevent and manage 
osteoporotic fractures.
 ► Implementation will be supported by national 
organisations, professional and scientific 
societies, including patient leagues.
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Table 1 Categorisation of individuals at high- risk of fragility 
fracture
Osteopenia T score =<-1.0 to −2.5 SD
Osteoporosis T score =≤−2.5 SD
FRAX 10- year probability of a major* 
osteoporotic fracture
≥20% (age independent)
FRAX 10- year probability of hip fracture ≥3% (age independent)
FRAX NOGG threshold 40 to 90 years (age dependent)
Note: T score, unit of SD from the mean for bone mineral density compared with 
a healthy young adult; FRAX, Fracture Risk Assessment Tool; NOGG, National 
Osteoporosis Guideline Group.
FRAX intervention thresholds vary between countries.
*A clinical spine, hip, forearm or humerus fracture.
Key messages
How might this impact on clinical practice or future 
developments?
 ► Improved care delivered by non- physician health 
professionals to prevent and manage fragility fractures offers 
opportunities for better health outcomes in older people in 
Europe.
fracture is substantial,5 6 highlighting the importance of primary 
and secondary fracture prevention.
Interventions delivered by non- physician health professionals 
(HPs), such as dietitians, nurses, occupational therapists, phar-
macists and physiotherapists, in close collaboration with rheu-
matologists, orthopaedic surgeons, rehabilitation specialists and 
general practitioners, are important in the management of patients 
at high- risk of fragility fractures. Interventions by non- physician 
HPs include exercise and functional training, prescription of assis-
tive devices, fall prevention programmes, nutritional supplements 
and education. Drug therapy is important in the prevention and 
management of fractures, and in some countries non- physician 
HPs can prescribe anti- osteoporosis medicines.7
The European League Against Rheumatism (EULAR) Standing 
Committees recognise the importance of optimising healthcare 
delivered by non- physician HPs to people at high- risk of fragility 
fractures. The EULAR/EFORT (European Federation of National 
Associations of Orthopaedics and Traumatology) recommenda-
tions for management of patients older than 50 years with a fragility 
fracture and prevention of subsequent fracture,8 focussed primarily 
on physician- based interventions. Interventions delivered by non- 
physician HPs were not comprehensively covered. Therefore, this 
study aimed to establish EULAR points to consider for the preven-
tion and management of fragility fractures by non- physician HPs 
to complement and extend the EULAR/EFORT recommendations. 
As there is considerable variation across European countries in the 
roles and tasks of HPs, we focussed on interventions that could 
potentially be delivered by non- physician HPs independent of 
whether specific HPs do certain interventions in a country or not.
MeTHOds
Points to consider were developed in accordance with up- to- date 
EULAR standard operating procedures for EULAR- endorsed 
recommendations.9 An international multidisciplinary task force 
was established, comprising two patient research partners, one 
dietitian, one geriatrician and one nurse, three occupational 
therapists, two orthopaedic surgeons, four physiotherapists, one 
specialist in physical medicine and rehabilitation and five rheuma-
tologists, with expertise in the management of osteoporosis and/or 
fragility fractures. A Delphi survey, conducted by email, was under-
taken to set up and prioritise the clinical questions on a 9- point 
Likert- scale (scores 1 to 3 ‘not relevant’, scores 4 to 6 ‘potentially 
relevant’, scores 7 to 9 ‘(highly) relevant’). Thirteen questions 
were reduced to eight via two rounds of voting by the task force 
(questions scoring <4 were excluded, questions scoring >6 were 
included and questions scoring 4 to 6 were discussed and revised). 
This was followed by a systematic literature review (SLR) based 
on the eight clinical questions (online supplementary file 1, table 
1) formulated around two linked concepts: (i) adults ≥50 years 
of age at high- risk of primary or secondary osteoporotic fracture 
and (ii) interventions delivered by non- physician HPs to prevent 
and manage osteoporotic fractures. High- risk of osteoporotic frac-
ture was categorised based on bone mineral density (BMD) values 
for osteoporosis and osteopenia10 and/or short- term probability of 
fracture (table 1). Key outcomes were fractures and falls, although 
BMD and risk of falling were included as surrogate endpoints.
Evidence was appraised using a domain- based assessment of 
risk of bias for primary studies,11 and A MeaSurement Tool to 
Assess systematic Reviews (AMSTAR 2)12 and classified using the 
Oxford 2011 Levels of Evidence Table13 (online supplementary 
file 1, tables 2-5). Evidence was rated as: sufficient, some, insuf-
ficient and insufficient evidence to determine14 (online supple-
mentary file 1, table 6). The research fellow (NW), and one 
convenor (EH), extracted data for the SLR in close collaboration 
with the methodologist (TAS). This SLR has been published.15
The task force met for one face- to- face meeting to review the 
results of the SLR and formulated the points to consider; these 
were finalised over subsequent weeks by online discussions and 
circulated to all task force members for voting via email. The 
level of agreement for the overarching principles and each point 
to consider was assessed using a numerical rating scale from 0 
(complete disagreement) to 10 (complete agreement). In parallel 
with this, research and education agendas for the non- physician 
HP workforce to prevent and optimally manage fragility frac-
tures were proposed and developed via a single round of itera-
tive online discussion among the task force.
ResulTs
Two overarching principles to underpin high quality care were 
supported by the task force; shared decision- making16 and multi- 
professional working. Shared decision- making is an essential 
component of personalised care17 and may reduce unwarranted 
variation in healthcare practice,18 while involving non- physician 
HPs in the treatment and management of patients at high- risk 
of fragility fracture widens opportunities to prevent and opti-
mally manage fragility fractures. Currently, non- physician HPs 
are only sometimes involved in the organisation and delivery of 
care for patients at high- risk of fracture.
Seven points to consider, describing non- pharmacological 
interventions, were developed and are summarised in table 2, 
along with underpinning levels of evidence, strength of recom-
mendations and level of agreement among task force members.
Point to consider 1: identification of patients at risk of 
fracture
No studies evaluating the effect of fracture risk detection by non- 
physician HPs were included in the SLR. Case finding people at 
risk of fracture can be undertaken in the first instance through 
identification of clinical factors (for example age, low body mass 
index, smoking, family fracture history, height loss ≥4 cm or a 
thoracic kyphosis).19 20 Simple online assessment tools incorpo-
rating various clinical risk factors (with or without a measure of 
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Table 2 Overarching principles and EULAR points to consider for the prevention and management of fragility fracture by non- physician HPs
no Overarching principles level of Agreement (Mean (sd))
1 The management of patients at risk of a fragility fracture should be based on shared decision making between patients and non- physician 
HPs.
9 (1.8)
2 non- physician HPs should be involved in the management of patients at risk of fragility fractures. 8.4 (2.2)
no Point to consider level of evidence strength of recommendation level of Agreement (Mean (sd))
Prevention of Fragility Fractures Median (Range)
1 Identification of patients at risk of fracture
Non- physician HPs should identify patients at risk of fragility fracture, ensure that the 




2 Fall risk evaluation
Non- physician HPs should start with fall risk evaluation of patients at risk of fragility fracture. 
Patients at high- risk of falls should be assessed by non- physician HPs using an individualised 
approach to multi- component screening or referred to one or more non- physician HPs 
competent in multi- component screening.
4 C
9.61 (0.70)
10 (8 to 10)
3 Preventive multicomponent interventions
Tailored multicomponent interventions, including for example:
 ► Exercise 1 to 3 A
9.33 (0.91) ► Environmental adaptations 2 D
 ► Nutrition 1 to 2 D 10 (8 to 10)
 ► Education 2 D
should be offered to patients at high- risk of primary osteoporotic fracture and/or high- risk 
of falls
4 Avoidance of smoking and overuse of alcohol
Smoking and overuse of alcohol should be discouraged. 1 A 9.22 (1.31)
10 (5 to 10)
no Point to consider level of evidence strength of recommendation level of Agreement (Mean (sd))
Management of Fragility Fractures Median (Range)
5 exercise and nutritional interventions for patients who have experienced a fragility 
fracture
Non- physician HPs should ensure that patients who have experienced a fragility fracture are 
given opportunities for:
 ► adequate exercise 1 to 2 A
9.22 (0.88) ► adequate nutritional intake 2 D
Calcium and vitamin D intake should be discussed with the patient focussing on actual and 
recommended daily calcium intake, calcium and vitamin D rich foods, and the individual’s 
risk/benefit profile for vitamin D supplementation.
1 to 2 D 9.5 (8 to 10)
6 Organisation and coordination of multidisciplinary services
Non- physician HPs should be included in orthogeriatric services, FLS and/or a coordinated, 
multidisciplinary post- fracture prevention programme. Patients with fragility fractures should 




10 (6 to 10)
7 Adherence to anti- osteoporosis medicines
Non- physician HPs should address, monitor and support medication adherence in a 
structured follow- up.
2 to 3 B 8.83 (1.25)
9 (6 to 10)
EULAR, European League Against Rheumatism; FLS, fracture liaison services; HPs, health professionals.
BMD) into a fracture risk algorithm (such as the Fracture Risk 
Assessment Tool (FRAX),21 Garvan22 and QFracture23) are freely 
available in many countries24 and recent evidence suggests that 
FRAX- based screening and guided management of community- 
dwelling older women, may reduce incident hip fractures, but 
not overall fractures.25 Given the centrality of risk assessment 
to fracture prevention, the task force agreed that non- physician 
HPs should identify patients at risk of fragility fracture.
Risk identification and stratification can facilitate appro-
priate management, and workforce developments over recent 
decades have widened opportunities for non- physician HPs to 
manage individuals at risk of fragility fracture.26 27 National 
and local practice policies and pathways can be established to 
support requests for laboratory testing and diagnostic inves-
tigations (such as dual- energy X- ray absorptiometry scans) 
by non- physician HPs, and implementation of non- medical 
prescribing could increase patient access to effective osteo-
porosis treatment.7 27 As an example, Bowers et al28 reported 
higher anti- fracture medicine prescription rates for women at 
high- risk of fragility fracture with implementation of a collab-
orative pharmacist- physician model of management compared 
with physician- only management.
Point to consider 2: fall risk evaluation
Initial assessment of risk of falls in adults at high- risk of fragility 
fracture should focus on key questions relating to: any history 
of falls within the past 12 months, fear of falling and/or feeling 
unsteady while walking or standing.29 A positive response in any 
of these areas should be followed up with a multifactorial falls- 
risk assessment incorporating evaluation of gait and mobility 
(measured for example by the Timed Up and Go test30) and other 
relevant factors, such as balance, lower limb strength, medi-
cation, postural dizziness/hypotension, vision, mental health 
and cognitive capacity, footwear and environmental factors.29 
Although the evidence identified in the SLR was insufficient to 
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determine benefit of fall risk evaluation in adults at high- risk of 
fragility fracture, the task force agreed that a multifactorial falls 
risk assessment should be done (by one appropriately skilled HP 
or a number of different HPs31) as, when followed by multifacto-
rial fall prevention interventions, multifactorial falls risk assess-
ment involving non- physician HPs may reduce rate of falls in 
older people when compared with other approaches.32 33
Point to consider 3: preventative multicomponent 
interventions
Multicomponent interventions, including for example exercise, 
fall- prevention strategies and education about bone health are 
important in primary fragility fracture prevention. Such multi-
component interventions may reduce fall rate and positively 
influence bone health in older people at high- risk of fragility 
fracture and/or at high- risk of falls.34–36
Regular long- term exercise is essential for bone 
health.37 38 Weight- bearing impact exercise and/or resistance 
training promotes strong bones and improves physical perfor-
mance,38 while exercise interventions incorporating balance and 
functional training reduce rate of falls and number of fallers in 
older people at high- risk of falls living in the community.39
In people with bone fragility, we found sufficient evidence 
that multicomponent exercise incorporating dynamic weight- 
bearing, strength and balance training undertaken 2 to 3 days 
a week for at least 10 weeks, reduces risk of falling,40 and some 
evidence that multicomponent exercise undertaken for >1 year 
positively influences BMD.35 41 Evidence about whole body 
vibration or low impact exercise is limited and insufficient to 
determine effect on bone health- related outcomes in people with 
bone fragility.42 43
Customised multifactorial interventions, targeting individ-
ualised fall- risk factors, may reduce the incidence in falls rate 
in community- dwelling older people at high- risk of falling.32 33 
One randomised controlled trial (RCT),36 reported a reduced 
falls rate in participants attending fall prevention clinics in 
Finland who received, on average, five fall and injury prevention 
interventions, commonly including home hazard modification, 
nutrition and lifestyle advice, medicines review and strength and 
balance training delivered by different HPs, including nurses and 
physiotherapists. The incidence rate of falls per 100 person years 
over a 12- month period were 95 in the intervention group and 
131 in the control group (incidence rate ratio 0.72, 95% CI 0.61 
to 0.86; p<0.001). The number needed to treat to prevent one 
fall was three.36
Data about the effect of nutrition on bone health- related 
outcomes in people with osteoporosis or osteopenia are limited. 
The evidence identified in our SLR was insufficient to deter-
mine the effect of vitamin D analogues, non- soy protein or daily 
vitamin K on BMD or fractures in older women with T scores 
between −1 and ≥−2.5.44–46 Nonetheless, maintenance of a 
healthy weight, increased consumption of fresh fruit and vege-
tables, lowering sodium intake and ensuring country- specific 
recommended intake levels of dietary calcium, may favourably 
impact bone health.47 Adequate serum levels of vitamin D are 
important for good musculoskeletal health, although the effect 
of supplementation on bone health- related outcomes remains 
contested.48–50 Analysis of pooled data from RCTs showed 
vitamin D supplementation had no effect on falls (n=34 144, 
relative risk (RR) 0.97, 95% CI 0.93 to 1.02) or total fractures 
(n=44 790, RR 1.00, 95% CI 0.93 to 1.07).51
The effect of face- to- face patient education on bone health- 
related outcomes in people with bone fragility is uncertain.52 In a 
systematic review including 13 RCTs of mostly high or moderate 
risk of bias, outcomes, including knowledge about osteopo-
rosis, initiation and adherence to osteoporosis medication and 
fractures, were mixed;52 less than half of the studies reported 
a statistically significant difference favouring the intervention.
Despite insufficient evidence to determine the effect of some 
interventions, the task force agreed that non- physician HPs 
should offer multicomponent interventions including nutri-
tion, multifactorial fall prevention initiatives and education, 
along with exercise (in particular supervised progressive weight- 
bearing, strength and balance training), to patients at high- risk of 
falls and or primary fragility fracture.
Point to consider 4: avoidance of smoking and overuse of 
alcohol
The negative impact of tobacco smoking on bone and bone- 
health related outcomes are widely recognised.53 Smoking 
adversely affects bone mass in some populations,54 55 and results 
from meta- analyses consistently demonstrate increased risk of 
osteoporotic fractures in people who currently smoke compared 
with never or non- smokers.56–59
High intakes of alcohol (more than two units/day or ≥50 g/
day) also increase fracture risk.60 61 The effects of alcohol on 
bone are complex and dose- dependent, and influenced by both 
direct and indirect mechanisms, such as alterations in activity 
and numbers of osteoblast and osteoclasts, hormonal changes 
and impaired nutrition.62 For some, the consequences of skeletal 
fragility are exacerbated by increased risk of falling63 mediated 
by intoxication and/or neuropathy.
Point to consider 5: exercise and nutritional interventions for 
patients who have experienced a fragility fracture
Following hip fracture surgery, structured exercise interventions, 
in particular interventions that incorporate progressive resis-
tance exercise training, result in small but significant improve-
ments in mobility and physical function.64 65 Multicomponent 
exercise, incorporating strength and balance training, reduces 
risk of falls in people who have experienced an osteoporotic 
fracture,40 while regular long- term resistance and weight- bearing 
exercise may favourably affect BMD.41 Evidence about the 
optimal frequency, intensity and duration of exercise for people 
with osteoporotic fracture is limited. However, several country- 
specific recommendations drawing on expert consensus, in 
combination with evidence, are available to guide practice.66 67
Concerning the effect of nutrition on bone health, insuffi-
cient evidence was found to determine the effect of oral protein 
supplementation on functional outcomes in people following 
hip fracture68 while vitamin D (800 IU) and calcium (1000 mg) 
supplementation in older people with a history of osteoporotic 
fracture appeared generally ineffective in preventing future hip 
or any new fracture.69 One RCT, at low risk of bias, investigated 
the effect of a single loading dose of vitamin D3 compared with 
a placebo injection administered to older people within 7 days 
of hip fracture surgery.70 At 4 weeks there was no statistically 
significant between- group difference in fracture incidence, but 
the falls rate of participants in the active group was 250 (number 
of falls/days x 1000) compared with 821.4 in the placebo group 
(absolute risk reduction 57.1%).
The task force considered these findings and agreed that non- 
physician HPs should encourage adequate nutrition for patients 
with a history of osteoporotic fracture and discuss vitamin D and 
calcium intake with them, focussing on actual and recommended 
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box 1 Research agenda to prevent and optimally manage 
fragility fractures for non- physician health professionals 
(HPs) including (but not limited to) dietitians, nurses, 
occupational therapists, pharmacists and physiotherapists
 ► Randomised clinical trials on the effect of non- 
pharmacological interventions, as well as interventions to 
facilitate adherence.
 ► Research studies need to define and qualify those at high- risk 
of fragility fracture in patient sample populations.
 ► Research studies investigating interventions to prevent falls 
and fragility fractures need to clearly record fracture status at 
baseline.
 ► Validation and reliability testing of (multicomponent) 
screening methods for risk of falling is needed.
 ► Research studies need to include long- term follow- up 
measures of bone health, incidence rates of falls and 
fractures and functional mobility outcomes.
 ► A consensus agreement and statement between relevant 
stakeholders on the definition of high- risk of secondary 
fracture is required.
 ► Further clinical trials to evaluate the cost- effectiveness of 
management of patients with osteoporosis and/or a (high- 
risk) of fragility fractures by non- physician HPs are needed.
 ► Research studies to identify the clinically effective optimal 
duration, intensity and frequency of interventions delivered 
by non- physician HPs to patients following fragility fracture 
should be conducted.
box 2 non- physician health professional (HP) education 
agenda to prevent and optimally manage fragility 
fractures
non- physician HPs should be educated on:
 ► How to use (multicomponent) screening tools to understand 
fracture risk.
 ► How to deliver, and what to include in a falls prevention 
programme.
 ► How to tailor education for people and patients with varying 
risk of falls.
 ► The scope and role of non- physician HPs in fracture liaison 
services.
 ► How to support and promote medication adherence.
 ► How to effectively promote bone health.
 ► Medication side effects that impact on bone health.
Education standards need to be agreed and underpinned by learning 
principles.
daily calcium intake, calcium and vitamin D rich foods and the 
individual’s risk/benefit profile for vitamin D supplementation.
Point to consider 6: organisation and coordination of 
multidisciplinary services
The clinical and cost- effectiveness of coordinated multidis-
ciplinary post- fracture models of care was confirmed in our 
SLR.71–73 Orthogeriatric services, delivering collaborative multi-
disciplinary inpatient care to older people admitted with hip frac-
ture, reduce relative risk of in- hospital and long- term mortality 
compared with standard care. Functional recovery and factors 
associated with risk of falling may also be positively impacted by 
early multidisciplinary HP team care approaches.74 75
Alongside, multidisciplinary fracture liaison services (FLS), in 
which non- physician HPs such as nurses, pharmacists and phys-
iotherapists effectively coordinate case finding, risk stratification 
and secondary fracture prevention,76 reduce re- fracture rates. 
In a meta- analysis of 19 519 participants who had experienced 
an osteoporotic fracture, a FLS compared with no FLS or usual 
care reduced absolute risk of re- fracture rate by approximately 
30%.72 Irrespective of the care model or country, FLS when 
compared with usual care or no treatment are cost- effective.73
Many countries in Europe have now implemented coordi-
nated post- fracture multidisciplinary models of care based on 
best practice standards,77 and the task force recommended that 
non- physician HPs should be included in these services.
Point to consider 7: adherence to anti-osteoporosis medicines
Despite the efficacy of anti- fracture pharmaceuticals,78 79 rates of 
non- adherence to anti- osteoporosis medicines are high80 81 and 
adversely affect outcomes.82 Non- adherence to medicines can be 
characterised by non- initiation of a prescription, suboptimal imple-
mentation and premature discontinuation of treatment.83 Inter-
ventions to improve adherence commonly target drug regimens, 
systems, providers and patients, although effects are inconsistent 
in people with chronic health problems.84 There is some evidence 
that interventions delivered by HPs (education, less frequent dosing 
regimens, electronic prescription and pharmacist- delivered osteo-
porosis management services) may improve adherence to anti- 
osteoporosis medications.85–87 Consequently, the task force agreed 
that non- physician HPs should evaluate medication adherence in 
patients prescribed anti- osteoporosis medicines, and explore ways 
to improve adherence.
Research and education agenda
The research and education agendas (boxes 1 and 2), support the 
development of capability and capacity within the non- physician 
workforce to prevent and optimally manage fragility fractures in 
adults 50 years or older. We recommend that consensus- derived 
core competencies are identified and embedded in HP education 
and training.
dIsCussIOn
These EULAR points to consider, underpinned by shared decision- 
making and multi- professional working complement the previous 
EULAR/EFORT recommendations.8 They provide a template 
for the organisation and delivery of healthcare by non- physician 
HPs to prevent and manage fragility fractures and contribute to 
holistic patient management.88 In addition to fall risk evaluation 
and interventions delivered by non- physician HPs, the task force 
developed a separate point to consider, focussed on adherence 
to medicines. While some non- physician HPs prescribe medi-
cines, all non- physician HPs should address, monitor and support 
adherence to prescribed anti- osteoporosis medicines in patients at 
risk of fragility fracture.
We acknowledge that patient management and HP roles and 
responsibilities differ across countries. However, these points 
can be tailored and used jointly by stakeholders as a focus for 
contextualised formative evaluations about implementation of 
interventions delivered by non- physician HPs, underpinned 
by country- specific patient level data from audit databases 
and registries.89–91 The generation of this knowledge, in 
conjunction with the identification of contextual barriers and 
facilitators to optimal management and implementation strat-
egies,92 93 could enhance the role and impact of non- physician 
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HPs working alongside medical colleagues to deliver services 
for this patient population.
We recommend that education about osteoporosis, fall and 
fracture risk assessment, and interventions to prevent and opti-
mally manage fragility fractures, should be a core component 
of non- physician HP undergraduate training. An interdisci-
plinary focus through generic competencies for non- physician 
HPs in fragility fracture prevention and management, may lead 
to more consistent and effective care, and tackle the personal, 
societal and economic burden associated with fracture events.
The low levels of evidence for some points to consider call 
for well- designed research studies that include specific non- 
physician HP interventions. Such studies should consider using 
behavioural change techniques to enhance adherence to inter-
ventions delivered by non- physician HPs and optimise service 
delivery to prevent and manage fragility fractures.
Our study has some limitations. First, over half of our 
points to consider were formulated wholly or in part based 
on the expert opinion of the task force, due to insufficient 
published research evidence. Our definition of high- risk popu-
lations probably excluded evidence from other studies exam-
ining commonly used interventions, such as multifactorial 
falls prevention strategies for other older adult populations. 
Second, our SLR preferentially selected systematic reviews and 
large RCTs and may have excluded some studies. Third, while 
data extraction and risk of bias judgements were conducted 
systematically, duplicate independent assessments would have 
added further value. Lastly, the addition of a general practi-
tioner on the task force would have been beneficial.
COnClusIOn
The personal, societal and economic burdens associated with 
fragility fractures are enormous. These EULAR points to 
consider, based on robust development processes and agreed 
by an international task force, can guide non- physician HPs in 
the prevention and management of fragility fractures in adults 
50 years or older.
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